The Skinny on Weight Loss Drugs

Double Take By Newton - A podcast by Newton Investment Management North America LLC

Categories:

Business

As the obesity epidemic rages across the globe, new weight loss drugs have become so popular that some manufacturers are unable to meet patient demand. Dr. David Katz, founder and CEO of Diet ID, joins Double Take to discuss investment ramifications of these hotly demanded medications.